生物
2019年冠状病毒病(COVID-19)
病毒学
核糖核酸
2019-20冠状病毒爆发
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
遗传学
基因
传染病(医学专业)
医学
疾病
病理
爆发
作者
Christopher J. Wayne,Anna K. Blakney
出处
期刊:Cell
[Elsevier]
日期:2024-04-01
卷期号:187 (8): 1822-1822.e1
标识
DOI:10.1016/j.cell.2024.03.018
摘要
In November 2023, Japan's Ministry of Health, Labour and Welfare granted regulatory approval of ARCT-154, a self-amplifying RNA COVID-19 vaccine developed by Arcturus Therapeutics. Clinical trials showed comparable safety and efficacy using a lower dose compared to the mRNA vaccine BNT162b2. To view this Bench-to-Bedside, open or download the PDF.
科研通智能强力驱动
Strongly Powered by AbleSci AI